VIRMA and intrahepatic cholangiocarcinoma: As shown in Fig. 9c–f, tumor growth of HuCCT1 ICC cells was significantly faster than that in the PBS group after CCL3 treatment, while HuCCT1 cells with VIRMA knockdown grew slower even after receiving CCL3 stimulation.